On August 30, 2021 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including Citi’s 16th Annual BioPharma Virtual Conference taking place September 8-10, 2021, the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021 and the 2021 Cantor Virtual Global Healthcare Conference taking place September 27-30, 2021 (Press release, CymaBay Therapeutics, AUG 30, 2021, View Source [SID1234586997]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual BioPharma Virtual Conference
Date: Thursday, September 9
Time: 1-on-1 meetings only

H.C. Wainwright 23rd Annual Global Investment Conference
Date: Monday, September 13
Time: 7:00 am Eastern Time / Fireside Chat
Webcast: View Source

2021 Cantor Virtual Global Healthcare Conference
Date: Tuesday, September 28
Time: 3:20 pm Eastern Time / Fireside Chat
Webcast: View Source